Literature DB >> 15075999

Fatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis.

Tetsuhiro Chiba1, Shigemasa Goto, Osamu Yokosuka, Fumio Imazeki, Masamichi Tanaka, Kenichi Fukai, Yoko Takahashi, Hideki Tsujimura, Hiromitsu Saisho.   

Abstract

We report a 22-year-old female who presented with pyrexia, pancytopenia and liver dysfunction. The patient showed mild liver dysfunction with low-grade fever and mild hepatosplenomegaly 6 years previously, and autoimmune hepatitis (AIH) was diagnosed based on the examination of the laboratory data and liver biopsy. On admission, both markers of Epstein-Barr virus (EBV) and in-situ hybridisation from a liver biopsy specimen indicated chronic active EBV infection (CAEBV). The patient was administered an immunosuppressive agent and antiviral drug added to steroid therapy, but ultimately died from liver failure and virus-associated haemophagocytosis 10 months after the definite diagnosis. Retrospective examination of the serum at the diagnosis of AIH revealed extremely high titres of antibody to EBV, and EBV-DNA was also detectable by polymerase chain reaction. These results suggest the possibility that the patient may already have suffered from CAEBV at the initial diagnosis. We presume that hepatic involvement of CAEBV should be considered as differential diagnosis in cases showing liver dysfunction with clinical and biochemical features observed in AIH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075999     DOI: 10.1097/00042737-200402000-00017

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  12 in total

Review 1.  Pathogens and autoimmune hepatitis.

Authors:  U Christen; E Hintermann
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

Review 2.  Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

3.  Autoimmune hepatitis following Epstein-Barr virus infection.

Authors:  Daniela Cabibi
Journal:  BMJ Case Rep       Date:  2008-11-20

Review 4.  Epstein-Barr virus: silent companion or causative agent of chronic liver disease?

Authors:  Mihaela Petrova; Victor Kamburov
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

5.  Chronic Active Epstein-Barr Virus Infection Indistinguishable from Autoimmune Hepatitis: A Case Report.

Authors:  Suguru Ikeda; Takaaki Sugihara; Takuya Kihara; Yoshiki Hoshino; Yukako Matsuki; Takakazu Nagahara; Kenji Oyama; Jun-Ichi Okano; Satoshi Kuwamoto; Yasushi Horie; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2022-04-13       Impact factor: 1.371

6.  EBV Chronic Infections.

Authors:  Pizzigallo Eligio; Racciatti Delia; Gorgoretti Valeria
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-10       Impact factor: 2.576

7.  Epstein-barr virus as a trigger of autoimmune liver diseases.

Authors:  Eirini I Rigopoulou; Daniel S Smyk; Claire E Matthews; Charalambos Billinis; Andrew K Burroughs; Marco Lenzi; Dimitrios P Bogdanos
Journal:  Adv Virol       Date:  2012-05-28

8.  Evaluation of the role of HLA-DR antigens in Japanese type 1 autoimmune hepatitis.

Authors:  Yohei Furumoto; Toru Asano; Tomonori Sugita; Hiroshi Abe; Yoshimichi Chuganji; Kazuhiko Fujiki; Akihiko Sakata; Yoshio Aizawa
Journal:  BMC Gastroenterol       Date:  2015-10-21       Impact factor: 3.067

Review 9.  Beta and Gamma Human Herpesviruses: Agonistic and Antagonistic Interactions with the Host Immune System.

Authors:  Mario E Cruz-Muñoz; Ezequiel M Fuentes-Pananá
Journal:  Front Microbiol       Date:  2018-01-05       Impact factor: 5.640

10.  Increased Incidence of Post-transplant Lymphoproliferative Disorder in Autoimmune Liver Disease: An Irish National Experience.

Authors:  Ahmed Abu-Shanab; Yasser Ged; Naeem Ullah; Diarmaid Houlihan; Aiden McCormick
Journal:  J Clin Exp Hepatol       Date:  2017-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.